Treace Medical Concepts, Inc. (NasdaqGS:TMCI) entered into an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC for $30 million on June 1, 2023. As reported, the purchase price is $20 million in an upfront cash payment, with up to $10 million in potential milestone payments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.875 USD | +2.26% | +13.86% | -53.92% |
05-29 | Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing | MT |
05-17 | North American Morning Briefing : The "Everything -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.92% | 364M | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+12.58% | 5.39B | |
-16.21% | 4.84B | |
+26.90% | 4.53B | |
-22.63% | 3.91B | |
-22.99% | 2.91B | |
+47.42% | 2.37B | |
-0.50% | 2B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. entered into an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC for $30 million.